NOI to Sole Source to 10X Genomics
Summary
The National Institutes of Health intends to award a sole‑source contract to 10X Genomics for reagents and consumables required for the Early Detection of Lung Diseases (EDLI) project, specifically the GEM‑X Universal 5' Gene Expression v3 Kit used with the 10X Genomics Chromium platform. The purchase is critical to maintain experimental continuity, data accuracy, and reproducibility in high‑resolution single‑cell and multi‑omic analyses aimed at identifying early lung disease biomarkers.